HBK Investments’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-220,692
Closed -$1.52M 923
2021
Q1
$1.52M Buy
+220,692
New +$1.87M 0.01% 528
2020
Q3
Sell
-123,702
Closed -$587K 673
2020
Q2
$617K Buy
+123,702
New +$421K 0.01% 430
2020
Q1
Sell
-70,102
Closed -$384K 397
2019
Q4
$384K Hold
70,102
﹤0.01% 594
2019
Q3
$401K Buy
+70,102
New +$476K 0.01% 562
2018
Q4
Sell
-22,757
Closed -$255K 1357
2018
Q3
$392K Sell
22,757
-12,592
-36% -$187K ﹤0.01% 999
2018
Q2
$493K Buy
+35,349
New +$597K ﹤0.01% 807

Other funds holding PGEN

HBK Investments's PGEN Position: Q2 2021 in Review

HBK Investments sold out of Precigen (PGEN) in Q2 2021, closing a stake of 220,692 shares — an estimated $1.52M sold.

HBK Investments first reported a position in PGEN in Q2 2018 and held it in 6 quarters. The position peaked at $1.52M in Q1 2021. 150 funds tracked by Wall St. Rank hold PGEN as of Q2 2021.

  • HBK Investments reported no remaining Precigen position as of Q2 2021 after selling out during the quarter.
  • HBK Investments sold 220,692 Precigen shares in Q2 2021, an estimated $1.52M.
  • HBK Investments first reported a position in Precigen in Q2 2018 and held it in 6 quarters.
  • HBK Investments's Precigen position peaked at $1.52M in Q1 2021.
  • 150 funds tracked by Wall St. Rank held Precigen as of Q2 2021.

Based on HBK Investments's 13F filing for Q2 2021, filed 16 Aug 2021.